Casey Younkin, MD

Associate Professor, Department of Obstetrics and Gynecology

    About me

    • Board Certified Obstetrics and Gynecology
    • Certified with the International Society of Clinical Densitometry
    • Specialties:
      • Obstetrical Care of the Low and High Risk Patient
      • Outpatient Surgery
      • Office Gynecology
      • Postmenopausal Bone Loss
      • Minimally Invasive Surgery
    • Clinic Locations:

    Videos

    Remote video URL

    Gender

    Male

    Education & training

    Positions
    Obstetrician and Gynecologist
    Board Certifications
    Obstetrics and Gynecology
    Medical School
    Washington University School of Medicine, St. Louis, MO
    Residency
    Barnes Hospital, St. Louis, MO - Obstetrics and Gynecology

    Research

    Research Interests
    Women's Health, Osteoporosis, and Menopause

    Publications

    Sumida, M., Want, T., Schwarz, A., Younkin, Froehlich, J.P.: The Ca++Atpase partial Reactions in Cardiac and Skeletal Muscle. J.biol Chem.255:1497-1503, 1980.

    Younkin, C., Petrie, R.H., Oxytocin: Its Use and Abuse. The Female Patient. 13:114-124, 1988.

    Younkin, C., Pelvic Inflammatory Disease: Treatment Options Reviewed. Hosp.Formulary 23:809-814, 1988.

    Awards

    • Healthfirst Clinic, Volunteer of the Year, 1997
    • APGO, Student Teaching, 2004
    • U.S. Top Doctors, 2005 - 2016
    • Best Doctors in America, 2011 - 2016

    Clinical trials

    Trial
    Obstetrics and Gynecology

    Biomarkers for Endometrial and Ovarian Cancer

    Active recruiting

    PURPOSE: This is a biological sample collection study aimed at developing an early diagnostic tool for endometrial and ovarian cancer. The investigators are studying the relationship between estrogen driven gynecological cancers, inflammation and the microbiome. Patients who have been diagnosed with endometrial cancer or undergo presurgical evaluation for suspicion of ovarian cancer who are scheduled for a hysterectomy, bilateral oophorectomy and/or salpingectomy are eligible. Control patients undergoing gynecological surgery for benign indications are also being recruited.